Radiopharmaceutical provider IBA Molecular has signed a five-year agreement with group purchasing organization Novation.
IBA will provide PET radiopharmaceuticals, including F-18 FDG, to imaging centers across the country, according to the company. IBA said it will also offer its PET education and support programs.
The agreement became effective on July 1.
